Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis

References

• Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem. 2010;56(6):930–940.
   PubMed Web of Science ®Google Scholar
• Meroni PL, Borghi MO, Grossi C, et al. Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases? Nat Rev Rheumatol. 2018;14(7):433–440.
   PubMed Web of Science ®Google Scholar
• D'Ippolito S, Marana R, Di Nicuolo F, et al. Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis. PLoS One. 2012;7(1):e29660.
   PubMed Web of Science ®Google Scholar
• Jiang C, Fang X, Jiang Y, et al. TNF-α induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model. Int J Biochem Cell Biol. 2016;72:118–124.
   PubMed Web of Science ®Google Scholar
• Uthman I, Noureldine MHA, Ruiz-Irastorza G, et al. Management of antiphospholipid syndrome. Ann Rheum Dis. 2019;78(2):155–161.
   PubMed Web of Science ®Google Scholar
• Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol. 2015;11(10):586–596.
   PubMed Web of Science ®Google Scholar
• Alvarez AM, Mulla MJ, Chamley LW, et al. Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. Arthritis Rheumatol. 2015;67(2):488–497.
   PubMed Web of Science ®Google Scholar
• Quao ZC, Tong M, Bryce E, et al. Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies. Am J Reprod Immunol. 2018;79(1):e12785.
   Web of Science ®Google Scholar
• Simone ND, D’Ippolito S, Marana R, et al. Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of beta(2) glycoprotein I. Am J Reprod Immunol. 2013;70(4):299–308.
   PubMed Web of Science ®Google Scholar
• Viall CA, Chamley LW. Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature. Autoimmun Rev. 2015;14(5):446–471.
   PubMed Web of Science ®Google Scholar
• Miranda S, Billoir P, Damian L, et al. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: role of reduced inflammation and endothelial dysfunction. PLoS ONE. 2019;14(3):e0212614.
   PubMed Web of Science ®Google Scholar
• Bertolaccini ML, Contento G, Lennen R, et al. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun. 2016;75:30–38.
   PubMed Web of Science ®Google Scholar
• Meroni PL. Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the Holy Grail we are looking for? J Autoimmun. 2016;75:1–5.
   PubMed Web of Science ®Google Scholar
• Pandey MK, Sung B, Ahn KS, et al. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol. 2009;75(3):525–533.
   PubMed Web of Science ®Google Scholar
• Albert CR, Schlesinger WJ, Viall CA, et al. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. Am J Reprod Immunol. 2014;71(2):154–164.
   PubMed Web of Science ®Google Scholar
• Zhao B, Ma A, Cai J, et al. VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells. Br J Ophthalmol. 2006;90(8):1052–1059.
   PubMed Web of Science ®Google Scholar
• Wu XX, Guller S, Rand JH. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression. Am J Obstet Gynecol. 2011;205(6):576 e7–e576 14.
   PubMed Web of Science ®Google Scholar
• Chetty C, Lakka SS, Bhoopathi P, et al. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer Res. 2008;68(12):4736–4745.
   PubMed Web of Science ®Google Scholar
• Ni L, Sun XQ, Zhao DX, et al. Low molecular weight heparin monotherapy for recurrent abortion with antiphospholipid system: A protocol of a systematic review. Medicine (Baltimore)). 2019;98(8):e14619
   PubMed Web of Science ®Google Scholar
• Schreiber K, Hunt BJ. Pregnancy and antiphospholipid syndrome. Semin Thromb Hemost. 2016;42(7):780–788.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69(1):20–28.
   PubMed Web of Science ®Google Scholar
• Marchetti T, Ruffatti A, Wuillemin C, et al. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost. 2014;12(6):910–920.
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48(11):3207–3211.
   PubMed Web of Science ®Google Scholar
• Languren M, Becerril B, Cabral AR, et al. Characterization of monoclonal anti-beta2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome. J Autoimmun. 2006;26(1):57–65.
   PubMed Web of Science ®Google Scholar
• Rahman RA, Murthi P, Singh H, et al. Hydroxychloroquine mitigates the production of 8-isoprostane and improves vascular dysfunction: implications for treating preeclampsia. IJMS. 2020;21(7):2504.
   Google Scholar
• Gomez-Guzman M, Jimenez R, Romero M, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2014;64(2):330–337.
   PubMed Web of Science ®Google Scholar
• Chen X, Jin X, Liu L, et al. Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer treatment. Fertil Steril. 2015;104(4):1030–1036.
   PubMed Web of Science ®Google Scholar
• Santi A, Felser RS, Mueller MD, et al. Increased endometrial placenta growth factor (PLGF) gene expression in women with successful implantation. Fertil Steril. 2011;96(3):663–668.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Luigi MP, Marco D, et al. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature. Ann N Y Acad Sci. 2007;1108:505–514.
   PubMed Web of Science ®Google Scholar
• Chamorro-Jorganes A, Lee MY, Araldi E, et al. VEGF-induced expression of miR-17-92 cluster in endothelial cells is mediated by ERK/ELK1 activation and regulates angiogenesis. Circ Res. 2016;118(1):38–47.
   PubMed Web of Science ®Google Scholar
• de la Torre YM, Pregnolato F, D'Amelio F, et al. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. J Autoimmun. 2012;38(2–3):J209–J215.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu J, He B, et al. Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model. Hum Reprod. 2015;30(9):2160–2170.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Di Nicuolo F, D'Ippolito S, et al. Antiphospholipid antibodies affect human endometrial angiogenesis. Biol Reprod. 2010;83(2):212–219.
   PubMed Web of Science ®Google Scholar
• Chen ML, Lin YH, Yang CM, et al. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res. 2012;56(6):889–899.
   PubMed Web of Science ®Google Scholar
• Kim M, Park HJ, Seol JW, et al. VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol Med. 2013;5(9):1415–1430.
   PubMed Web of Science ®Google Scholar
• Muller-Calleja N, Manukyan D, Canisius A, et al. Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase. Ann Rheum Dis. 2017;76(5):891–897.
   PubMed Web of Science ®Google Scholar
• Rand JH, Wu XX, Quinn AS, et al. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood. 2010;115(11):2292–2299.
   PubMed Web of Science ®Google Scholar